We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
37 new companies in the past 12 months, Nanopore's IPO on the horizon, and £400m+ investment in Q1 alone - get caught up with the latest from Oxford University Innovation.
OxVax, a spinout from Oxford University, has formed with the objective of producing vaccines for cancer.
The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer
World's first Conservation Venture Studio launches to boost Oxford's biodiversity innovation outputs.
Counterfeit medicine, which can prove both costly and deadly, target of new collaboration with Oxford University.
Your quarterly review of activity from Oxford University Innovation.
The breakthrough diagnostics platform will offer clinicians a new path to evaluating the potential advancement of Alzheimer's Disease.
TenU, the transatlantic collaboration of ten top technology transfer offices, has held its inaugural event bringing together university and government leaders.
Oxford spinout Spybiotech partners Serum Institute of India on new potential vaccine for COVID-19.
